Kamux Corporation's Annual Report 2024 has been published on the company’s website at kamux.com  . The Annual Report consists of three sections: Report by the Board of Directors and Financial ...

USD 50 billion commitment includes new state-of-the art research and development (R&D) sites, new and expanded manufacturing facilities in Indiana, Pennsylvania, Massachusetts and California and an ...

Roche, in collaboration with Universitätsklinikum Heidelberg, has developed a Chest Pain Triage algorithm – a CE-marked IVD medical device1 set to transform cardiac care; This ...

Solar Foods Oyj, press release 24 April 2025 at 11.00 EET. Solar Foods has developed Solein® Shake for daily protein needs. Solar Foods continues to develop product concepts to d ...

MoonLake Immunotherapeutics (Nasdaq: MLTX), a clinical-stage biotechnology company focused on creating next-level therapies for inflammatory diseases, will host a virtual Capital Markets Day for ...

Orion Corporation (“Orion”) and Criceto IKM B.V. (“Criceto”) today announced the signing of an exclusive license agreement for the development and commercialization of APORON®, a novel apomorphine ...

Entitled ‘ Unleashing America’s Offshore Critical Minerals and Resources ’, the Executive Order directs Commerce Secretary Lutnick to expedite deep seabed mineral exploration licenses and commercial ...

Orion Corporation has received a disclosure under Chapter 9, Section 5 of the Securities Market Act, according to which the total number of Orion shares owned directly, indirectly and through ...

About AGI AGI is a leading provider of high-performance storage solutions, dedicated to delivering innovative products that cater to the evolving needs of its customers. With a commitment to offering ...

Novel T cell engager ZW209 demonstrates durable activity in small cell lung cancer; IND submission expected in 1H-2026 ...

In the Chinese mainland, toripalimab was the first domestic anti-PD-1 monoclonal antibody approved for marketing (approved in China as TUOYI®). Currently, there are twelve approved indications for ...

The Board of Directors of Ponsse Plc established two share-based incentive plans for the CEO and key employees of the group in 2023. The key terms of the incentive plans were published in a stock ...